Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUL 6 ... Investment, Finance, Financial, InvestingBiotechnology Business, Biotechnology Company, InterMune Inc., Research and Markets. This article was prepared by Biotech Business Week ...
2009 NOV 16 ... of ARRY-380 in patients with advanced cancer. Array received a milestone payment from InterMune, Inc.: Array received a $1 million milestone payment from InterMune in August 2009 after ...
2009 SEP 28 ... hedge fund located in San Francisco. Previously, he served as CFO at Tercica, Inc. and InterMune, Inc. Mr. Lynch also worked in corporate development for Elan Corporation plc and began ...
2009 NOV 16 ... Pharmasset, Inc (NASDAQ:VRUS) and InterMune, Inc. (NASDAQ:ITMN) announced results from all patient cohorts of the INFORM-1 trial, an ...
2009 NOV 16 ... InterMune, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, InterMune Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 30 ... InterMune, Peginterferon Alfa-2a, Pharmaceuticals, Ribavirin, Therapy, Treatment, InterMune Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 16 ... Regulatory Actions, Respirology, Therapy, Treatment, U.S. Food and Drug Administration, InterMune Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 16 ... Protease Inhibitors, Respirology, Treatment, Viral Inhibition, Viral Therapy, Virology, InterMune Inc. This article was prepared by Biotech Business Week editors from staff and ...
